The Discounted Cash Flow (DCF) valuation of Neuropace Inc (NPCE) is (13.07) USD. With the latest stock price at 10.79 USD, the upside of Neuropace Inc based on DCF is -221.1%.
Based on the latest price of 10.79 USD and our DCF valuation, Neuropace Inc (NPCE) is a sell. selling NPCE stocks now will result in a potential gain of 221.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 8.9% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (27.67) - (9.14) | (13.07) |
| Upside | -356.4% - -184.7% | -221.1% |